Berry Oncology

BiotechnologySeries BFuzhou, Chinaberryoncology.com

Latest round

Series B

Last raised

Jul 2021

Total raised

$99M

Investors

10

About Berry Oncology

Established in 2017 and based in Fuzhou, China, Berry Oncology is a company that engages in the tumor genetic testing., Ltd. In 2018, the company and the National Liver Cancer Science Center jointly initiated a national multi-center prospective liver cancer very early warning screening project. The company's products include tumor genetic susceptibility analysis, early screening, targeted and immune drug testing, efficacy monitoring, prognostic judgment, etc. In the field of early tumor screening and diagnosis, the company has launched a clinical research project for early screening and early diagnosis of tumors including liver cancer and lung cancer.

Who invested in Berry Oncology

10 investors across 2 rounds

See all investors in Berry Oncology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 4, 2021

    Amount

    $99M

    Investors

    Locked

  2. Series A

    Nov 8, 2017

    Amount

    Undisclosed

    Investors

    Locked

Questions about Berry Oncology

Who invested in Berry Oncology?

Berry Oncology has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Berry Oncology raised?

Berry Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Berry Oncology last raise money?

Berry Oncology's most recent round on record is a Series B, in Jul 2021.

What does Berry Oncology do?

Established in 2017 and based in Fuzhou, China, Berry Oncology is a company that engages in the tumor genetic testing.

Where is Berry Oncology headquartered?

Berry Oncology is headquartered in Fuzhou, China.

Which VCs invest in companies like Berry Oncology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Berry Oncology's stage. Their profiles are linked below.

Raising like Berry Oncology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.